- Nachrichtendetail
-
31.05.2024 08:24:13 - dpa-AFX: *ABBVIE'S RISANKIZUMAB RECEIVES POSITIVE CHMP OPINION FOR TREATMENT OF ACTIVE ULCERATIVE COLITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE | A1J84E | NYSE | 171,520 | 28.06.24 22:02:29 | +2,530 | +1,50% | 170,500 | 171,180 | 170,710 | 168,990 |
